Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

7 Biggest Lithium-mining Companies in 2024

Could the Silver Price Really Hit $100 per Ounce? (Updated 2024)

Top 10 Oil-producing Countries (Updated 2024)

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

Where Does Tesla Get its Lithium? (Updated 2024)

Top 4 Largest Lithium Reserves by Country (Updated 2024)

Uranium Stocks: 5 Biggest Companies in 2024

Hydrogen Stocks: 9 Biggest Companies in 2024

Top 10 Countries for Natural Gas Production (Updated 2024)

Trending Press Releases

SIRONA BIOCHEM Poised for Profitability in 2025 with Anti-Aging Product Rollout

In Search of Alternative Financing for Critical Minerals Projects

Black Mountain: Strategy & Drilling Plans

CHARBONE Hydrogen Expands Expertise with Strategic Partnership to Lead in White Hydrogen Sector

Trillion Energy Initiates Velocity String Program

Large Scale Copper Discovery Confirmed

More Press Releases
Trending Companies

Saga Metals

SAGA:CA

Albemarle Corporation

ALB

Sociedad Quimica y Minera S.A. (SQM)

SQM:NYE

Vertex Minerals

VTX:AU
More Companies
Trending Reports

Nickel Investor Report

2024 Lithium Market Outlook

Silver Price Forecast - What Happened And Where Do We Go From Here?

2024 Copper Outlook Report

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Gold Price
Silver Price
Copper Price
Oil Price
Uranium
Artificial Intelligence
loader

Instil Bio

NASDAQ:TIL

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing an innovative cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment...

Press Releases
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing an innovative cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using our Co-Stimulatory Antigen Receptor, or CoStAR, platform. The company's lead product candidate, ITIL-168, is an autologous TIL therapy that it is initially developing for the treatment of PD-1-inhibitor relapsed or refractory advanced melanoma.

Interactive Chart

×